Medscape is available in 5 Language Editions – Choose your Edition here.


Internal Jugular Vein Thrombosis Treatment & Management

  • Author: Dale K Mueller, MD; Chief Editor: Vincent Lopez Rowe, MD  more...
Updated: Jul 20, 2016

Approach Considerations

Uncomplicated cases of internal jugular (IJ) vein thrombosis seldom require surgical intervention. Pharmacologic therapy may involve anticoagulants, thrombolytics, or antibiotics as indicated.

Rare indications for a superior vena cava (SVC) filter are similar to those of deep vein thrombosis (DVT) in the lower extremity when upper-extremity DVT is associated with an IJ vein thrombosis. These include the clinical setting of pulmonary embolism (PE) in which therapeutic anticoagulation has failed or is contraindicated. The contraindications for surgery are few but would include uncorrected coagulopathy and cardiac risks for the procedure that are believed to outweigh the benefits.


Pharmacologic Therapy

Once a diagnosis of IJ vein thrombosis is made, consideration should be given to initiating anticoagulant therapy. To date, unfortunately, there have been no studies of sufficient size to guide physicians in this area. Clearly, many patients do well without serious effects, as evidenced by the frequency with which IJ vein thrombosis is underdiagnosed.

The risk of PE is truly unknown. The most commonly quoted rate of PE occurring in the setting of IJ thrombosis is 5%; however, this statistic is taken from a relatively small retrospective study performed more than 25 years ago. A later retrospective study demonstrated PE rates of 0.5% and 2.4% for isolated IJ vein thrombosis and combined subclavian/axillary vein and IJ vein thrombosis, respectively.

Isolated case series have described the use of thrombolytic therapy in this setting, usually via catheters inserted directly adjacent to the thrombus. Most reports involved patients with extensive thrombus extending into the sigmoid sinus, in whom treatment caused few complications. However, neither the indications for nor the safety of thrombolytic treatment has been defined.

If an indwelling catheter is present, it should be removed. Exceptions to this policy are rare but include situations where no other options for venous access exist in a patient who would experience a life-threatening situation without it. When the indwelling catheter cannot be removed, the use of unfractionated heparin or low-molecular-weight heparin is recommended in the acute setting to prevent central propagation or symptomatic PE and to maintain any restored venous patency.[6]

In the setting of infection, many patients do well when given antibiotics alone, without anticoagulant therapy. However, in the presence of septic emboli or with clear evidence of clot propagation, many physicians choose to add systemic anticoagulation. The major risk involves further bleeding and even airway compromise from expanding hematoma, especially in association with central venous catheters.

In the setting of thrombophlebitis associated with central venous catheters, antibiotic therapy directed at gram-positive organisms should be promptly instituted. Vancomycin is a good initial choice and can be changed to nafcillin if culture data subsequently indicate sensitivity to methicillin. Daptomycin has also been approved for use in this setting.

In all other cases of infected IJ vein thrombus, prolonged antibiotic therapy specifically directed against anaerobic organisms should be promptly instituted as soon as blood cultures are obtained. Recommended antibiotics include ticarcillin-clavulanate and ampicillin-sulbactam. In patients with true anaphylaxis to penicillin, clindamycin, metronidazole, or chloramphenicol could be used as alternatives. For all cases of thrombophlebitis, therapy should be continued for 4-6 weeks.


Surgical Intervention

Although surgical intervention is rarely necessary for uncomplicated cases, IJ vein thrombosis associated with a deep neck infection calls for drainage of any fluid collections and debridement of all infected tissue. Likewise, extensive and complete debridement is warranted for cervical necrotizing fasciitis.

In patients with intraluminal abscesses, excision of the IJ vein may be required to prevent subsequent serious complications. However, most cases of postanginal sepsis can be managed medically, without the need for resection of the infected vein. Cases that do not respond to antibiotic therapy are unusual; it is important to remember that fever may persist for some time, especially in cases of metastatic infection.

The carotid sheath often protects the carotid artery. However, if this structure becomes involved, early and prompt surgical intervention is required to prevent devastating neurologic or airway complications.

Placement of superior vena cava filter

Indications for a Greenfield SVC filter are rare. No reports demonstrate the use of a SVC filter for an isolated IJ vein thrombosis. Indications for an SVC filter with axillary/subclavian vein thrombosis are similar to those of lower-extremity DVT, including upper-extremity DVT that extended to the IJ vein. Therefore, in the clinical setting of an axillary/subclavian vein thrombosis alone or combined with an IJ vein thrombus with PE in which therapeutic anticoagulation has failed or is contraindicated, a SVC filter should be inserted.

Before filter placement, superior vena cavograms are obtained in all patients to determine caval size and to exclude venous abnormalities and SVC thrombus.[7] Whenever possible, the filter is placed via the right common femoral vein. Placement is more difficult in the SVC than in the inferior vena cava (IVC) because the area for appropriate placement is smaller. For femoral vein insertion, a jugular insertion kit is used to facilitate orientation; for jugular vein insertion, a femoral insertion kit is used.

After the procedure, a chest radiograph should be obtained to assess for filter migration, dislodgment, or fracture.

Contributor Information and Disclosures

Dale K Mueller, MD Co-Medical Director of Thoracic Center of Excellence, Chairman, Department of Cardiovascular Medicine and Surgery, OSF Saint Francis Medical Center; Cardiovascular and Thoracic Surgeon, HeartCare Midwest, Ltd, A Subsidiary of OSF Saint Francis Medical Center; Section Chief, Department of Surgery, University of Illinois at Peoria College of Medicine

Dale K Mueller, MD is a member of the following medical societies: American College of Chest Physicians, American College of Surgeons, American Medical Association, Chicago Medical Society, Illinois State Medical Society, International Society for Heart and Lung Transplantation, Society of Thoracic Surgeons, Rush Surgical Society

Disclosure: Received consulting fee from Provation Medical for writing.


Michael J Dacey, MD Consulting Staff, Department of Internal Medicine, Division of Critical Care, Kent County Hospital

Disclosure: Nothing to disclose.

Chief Editor

Vincent Lopez Rowe, MD Professor of Surgery, Program Director, Vascular Surgery Residency, Department of Surgery, Division of Vascular Surgery, Keck School of Medicine of the University of Southern California

Vincent Lopez Rowe, MD is a member of the following medical societies: American College of Surgeons, American Heart Association, Society for Vascular Surgery, Vascular and Endovascular Surgery Society, Society for Clinical Vascular Surgery, Pacific Coast Surgical Association, Western Vascular Society

Disclosure: Nothing to disclose.


Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

  1. Righini CA, Karkas A, Tourniaire R, N'Gouan JM, Schmerber S, Reyt E, et al. Lemierre syndrome: study of 11 cases and literature review. Head Neck. 2014 Jul. 36(7):1044-51. [Medline].

  2. Ascher E, Salles-Cunha S, Hingorani A. Morbidity and mortality associated with internal jugular vein thromboses. Vasc Endovascular Surg. 2005 Jul-Aug. 39 (4):335-9. [Medline].

  3. Tovi F, Fliss DM, Gatot A, Hertzanu Y. Septic jugular thrombosis with abscess formation. Ann Otol Rhinol Laryngol. 1991 Aug. 100(8):682-4. [Medline].

  4. Fuhrman T, Balatbat J, Frakes J, Metz R. Internal jugular thrombosis causing increased intracranial pressure and upper airway edema. Internet J Anesthesiol. 1999. 4 (3):1-5. [Full Text].

  5. Kim BY, Yoon DY, Kim HC, Kim ES, Baek S, Lim KJ, et al. Thrombophlebitis of the internal jugular vein (Lemierre syndrome): clinical and CT findings. Acta Radiol. 2013 Jul. 54(6):622-7. [Medline].

  6. Sheikh MA, Topoulos AP, Deitcher SR. Isolated internal jugular vein thrombosis: risk factors and natural history. Vasc Med. 2002 Aug. 7 (3):177-9. [Medline]. [Full Text].

  7. Spence LD, Gironta MG, Malde HM, Mickolick CT, Geisinger MA, Dolmatch BL. Acute upper extremity deep venous thrombosis: safety and effectiveness of superior vena caval filters. Radiology. 1999 Jan. 210(1):53-8. [Medline].

All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.